Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
2,206 questions in 117 reviews · Common Mental Disorders
current versionsNo studies 387 · 17.5%Ungraded 111 · 5%Very low 635 · 28.8%Low 568 · 25.7%Moderate 449 · 20.4%High 56 · 2.5%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Behavioural activation vs waiting list anxiety symptoms(continuous) up to 6 months (4‐12 weeks) · depression in adults Behavioural activation therapy for depression in adults (2020) · Cochrane | no estimate extracted | 5 studies · 424 participants | Low |
Behavioural activation vs waiting list adverse events(6 weeks) · depression in adults Behavioural activation therapy for depression in adults (2020) · Cochrane | no estimate extracted | 0 studies · 1 participants | Ungraded |
Behavioural activation vs placebo treatment acceptabilityup to 6 months (16 weeks) · depression in adults Behavioural activation therapy for depression in adults (2020) · Cochrane | RR 0.72 [0.31, 1.67] | 1 study · 96 participants | Low |
Behavioural activation vs placebo depression symptoms(continuous) up to 6 months (2 weeks) · depression in adults Behavioural activation therapy for depression in adults (2020) · Cochrane | no estimate extracted | 2 studies · 108 participants | Low |
Behavioural activation vs placebo adverse events(16 weeks) · depression in adults Behavioural activation therapy for depression in adults (2020) · Cochrane | no estimate extracted | 1 study · 96 participants | Low |
Behavioural activation vs medication treatment efficacy up to 6 months (16 weeks) · depression in adults Behavioural activation therapy for depression in adults (2020) · Cochrane | RR 1.77 [1.14, 2.76] | 1 study · 141 participants | Moderate |
Behavioural activation vs medication treatment acceptabilityup to 6 months (12‐16 weeks) · depression in adults Behavioural activation therapy for depression in adults (2020) · Cochrane | RR 0.52 [0.23, 1.16] | 2 studies · 243 participants | Moderate |
Behavioural activation vs medication depression symptoms(continuous) up to 6 months (12‐16 weeks) · depression in adults Behavioural activation therapy for depression in adults (2020) · Cochrane | no estimate extracted | 2 studies · 180 participants | Low |
Behavioural activation vs medication adverse events(16 weeks) · depression in adults Behavioural activation therapy for depression in adults (2020) · Cochrane | no estimate extracted | 1 study · 143 participants | Moderate |
Behavioural activation vs no treatment treatment acceptabilityup to 6 months (2‐5 weeks) · depression in adults Behavioural activation therapy for depression in adults (2020) · Cochrane | RR 0.97 [0.45, 2.09] | 3 studies · 187 participants | Moderate |
Behavioural activation vs CBT quality of life (continuous)up to 6 months (12‐16 weeks) · depression in adults Behavioural activation therapy for depression in adults (2020) · Cochrane | no estimate extracted | 2 studies · 268 participants | Moderate |
Behavioural activation vs no treatment depression symptoms(continuous) up to 6 months (2‐5 weeks) · depression in adults Behavioural activation therapy for depression in adults (2020) · Cochrane | no estimate extracted | 3 studies · 187 participants | Moderate |
Behavioural activation vs no treatment quality of life (continuous)up to 6 months (5 weeks) · depression in adults Behavioural activation therapy for depression in adults (2020) · Cochrane | no estimate extracted | 1 study · 118 participants | High |
Behavioural activation vs no treatment anxiety symptoms(continuous) up to 6 months (2 weeks) · depression in adults Behavioural activation therapy for depression in adults (2020) · Cochrane | no estimate extracted | 1 study · 30 participants | Low |
Behavioural activation vs treatment treatment efficacyup to 6 months (5‐12 weeks) · depression in adults Behavioural activation therapy for depression in adults (2020) · Cochrane | RR 1.4 [1.1, 1.79] | 7 studies · 1533 participants | Moderate |
Behavioural activation vs treatment treatment acceptabilityup to 6 months (5‐12 weeks) · depression in adults Behavioural activation therapy for depression in adults (2020) · Cochrane | RR 1.64 [0.81, 3.31] | 14 studies · 2518 participants | Moderate |
Behavioural activation vs treatment depression symptoms (continuous) up to 6 months (5‐12 weeks) · depression in adults Behavioural activation therapy for depression in adults (2020) · Cochrane | no estimate extracted | 15 studies · 2208 participants | Low |
Behavioural activation vs treatment quality of life (continuous)up to 6 months (8‐12 weeks) · depression in adults Behavioural activation therapy for depression in adults (2020) · Cochrane | no estimate extracted | 6 studies · 1299 participants | Very low |
Behavioural activation vs treatment social adjustment and functioning (continuous)up to 6 months (12 weeks) · depression in adults Behavioural activation therapy for depression in adults (2020) · Cochrane | no estimate extracted | 2 studies · 88 participants | Low |
Behavioural activation vs treatment anxiety symptoms(continuous) up to 6 months (8‐12 weeks) · depression in adults Behavioural activation therapy for depression in adults (2020) · Cochrane | no estimate extracted | 4 studies · 1063 participants | Moderate |
Behavioural activation vs treatment adverse events(8‐10 weeks) · depression in adults Behavioural activation therapy for depression in adults (2020) · Cochrane | no estimate extracted | 3 studies · 1471 participants | Moderate |
Behavioural activation vs CBT social adjustment and functioning (continuous)up to 6 months (12 weeks) · depression in adults Behavioural activation therapy for depression in adults (2020) · Cochrane | no estimate extracted | 2 studies · 111 participants | Very low |
Behavioural activation vs CBT anxiety symptoms (continuous) up to 6 months (4‐16 weeks) · depression in adults Behavioural activation therapy for depression in adults (2020) · Cochrane | no estimate extracted | 4 studies · 646 participants | Moderate |
Behavioural activation vs CBT adverse events (16 weeks) · depression in adults Behavioural activation therapy for depression in adults (2020) · Cochrane | no estimate extracted | 2 studies · 398 participants | Moderate |
Behavioural activation vs third‐wave CBT treatment efficacy up to 6 months (4‐8 weeks) · depression in adults Behavioural activation therapy for depression in adults (2020) · Cochrane | RR 1.1 [0.91, 1.33] | 2 studies · 98 participants | Low |
Behavioural activation vs third‐wave CBT treatment acceptability up to 6 months (4‐8 weeks) · depression in adults Behavioural activation therapy for depression in adults (2020) · Cochrane | RR 0.84 [0.33, 2.1] | 3 studies · 147 participants | Low |
Behavioural activation vs any comparator Treatment efficacy for depression (short term: 8–9 weeks) · depression in adults with non‐communicable diseases Behavioural activation therapy for depression in adults with non‐communicable diseases (2020) · Cochrane | RR 1.53 [0.98, 2.38] | 2 studies · 176 participants | Low |
Behavioural activation vs any comparator Quality of life (medium term: 12 months) · depression in adults with non‐communicable diseases Behavioural activation therapy for depression in adults with non‐communicable diseases (2020) · Cochrane | no estimate extracted | 1 study · 80 participants | Low |
Behavioural activation vs any comparator Social adjustment and functioning (short term: 6 months) · depression in adults with non‐communicable diseases Behavioural activation therapy for depression in adults with non‐communicable diseases (2020) · Cochrane | no estimate extracted | 1 study · 80 participants | Low |
Behavioural activation vs any comparator Social adjustment and functioning (medium term: 12 months) · depression in adults with non‐communicable diseases Behavioural activation therapy for depression in adults with non‐communicable diseases (2020) · Cochrane | no estimate extracted | 1 study · 80 participants | Low |
Behavioural activation vs any comparator Improvement in anxiety symptoms (short term: 6 months) · depression in adults with non‐communicable diseases Behavioural activation therapy for depression in adults with non‐communicable diseases (2020) · Cochrane | no estimate extracted | 1 study · 80 participants | Low |
Behavioural activation vs any comparator Improvement in anxiety symptoms (medium term: 12 months) · depression in adults with non‐communicable diseases Behavioural activation therapy for depression in adults with non‐communicable diseases (2020) · Cochrane | no estimate extracted | 1 study · 80 participants | Low |
Behavioural activation vs any comparator Treatment efficacy for depression (medium term: 12 months) · depression in adults with non‐communicable diseases Behavioural activation therapy for depression in adults with non‐communicable diseases (2020) · Cochrane | RR 1.76 [1.01, 3.08] | 1 study · 92 participants | Moderate |
Behavioural activation vs any comparator Treatment efficacy for depression (long term: 24 months) · depression in adults with non‐communicable diseases Behavioural activation therapy for depression in adults with non‐communicable diseases (2020) · Cochrane | RR 1.42 [0.91, 2.23] | 1 study · 67 participants | Moderate |
Behavioural activation vs any comparator Treatment acceptability (short term: 2 months) · depression in adults with non‐communicable diseases Behavioural activation therapy for depression in adults with non‐communicable diseases (2020) · Cochrane | RR 1.81 [0.68, 4.82] | 1 study · 80 participants | Low |
Behavioural activation vs any comparator Treatment acceptability (medium term: 12 months) · depression in adults with non‐communicable diseases Behavioural activation therapy for depression in adults with non‐communicable diseases (2020) · Cochrane | RR 0.88 [0.25, 3.1] | 1 study · 101 participants | Low |
Behavioural activation vs any comparator Improvement in depression symptoms (short term: 5–6 months) · depression in adults with non‐communicable diseases Behavioural activation therapy for depression in adults with non‐communicable diseases (2020) · Cochrane | no estimate extracted | 2 studies · 176 participants | Low |
Behavioural activation vs any comparator Improvement in depression symptoms (medium term: 12 months) · depression in adults with non‐communicable diseases Behavioural activation therapy for depression in adults with non‐communicable diseases (2020) · Cochrane | no estimate extracted | 2 studies · 172 participants | Low |
Behavioural activation vs any comparator Improvement in depression symptoms (long term: 5 months) · depression in adults with non‐communicable diseases Behavioural activation therapy for depression in adults with non‐communicable diseases (2020) · Cochrane | no estimate extracted | 1 study · 67 participants | Moderate |
Behavioural activation vs any comparator Quality of life (short term: 6 months) · depression in adults with non‐communicable diseases Behavioural activation therapy for depression in adults with non‐communicable diseases (2020) · Cochrane | no estimate extracted | 1 study · 80 participants | Low |
Intervention NR Suicide (Observation period ‐ pre‐intervention: 119.5 years; postintervention: 92 years) · adults or children of all ethnicities Means restriction for the prevention of suicide by jumping (2020) · Cochrane | IRR 0.09 | 12 participants | Low |
Intervention NR Cost‐effectiveness of interventions · adults or children of all ethnicities Means restriction for the prevention of suicide by jumping (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Suicide (Observation period: pre‐intervention 30.5 years; postintervention 13.5 years) · adults or children of all ethnicities Means restriction for the prevention of suicide by jumping (2020) · Cochrane | IRR 0.54 | 3 studies · 3 participants | Low |
Intervention NR Attempted suicide · adults or children of all ethnicities Means restriction for the prevention of suicide by jumping (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Study withdrawal · adults or children of all ethnicities Means restriction for the prevention of suicide by jumping (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Change in hospital admission rates · adults or children of all ethnicities Means restriction for the prevention of suicide by jumping (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Cost‐effectiveness of interventions · adults or children of all ethnicities Means restriction for the prevention of suicide by jumping (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Suicide (Observation period: pre‐intervention 81.5 years; postintervention 71.8 years) · adults or children of all ethnicities Means restriction for the prevention of suicide by jumping (2020) · Cochrane | IRR 0.07 | 7 studies · 7 participants | Low |
Intervention NR Attempted suicide · adults or children of all ethnicities Means restriction for the prevention of suicide by jumping (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Study withdrawal · adults or children of all ethnicities Means restriction for the prevention of suicide by jumping (2020) · Cochrane | no estimate extracted | NR | No studies |